StockData
Aurora Cannabis Inc logo

Aurora Cannabis Inc (ACB) stock

ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 11, 2026Score 6/30
$4.52−0.09 (-1.95%)

Close on Nov 17, 2026Market cap $266.44MP/E –Yield –

Aurora Cannabis r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2026 it was C$4.02M, up 9.4% from the year before. The highest annual figure on record is C$26.03M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026C$4.02M+9.4%
FY2025Mar 31, 2025C$3.68M-64.6%
FY2022Jun 30, 2022C$10.39M-9.2%
FY2021Jun 30, 2021C$11.45M-56.0%
FY2020Jun 30, 2020C$26.03M+76.1%
FY2019Jun 30, 2019C$14.78M+780.2%
FY2018Jun 30, 2018C$1.68M–

More Aurora Cannabis figures

See a number that looks wrong?